Swiss Microfinance Report 2015 shows that Switzerland remains the leader in managing global microfinance investments
The recently updated Swiss Microfinance Investments Report confirms that Switzerland remains the world market leader in microfinance investments with 38% of global investments. This new report was prepared jointly by Symbiotics and University of Zurich – Center for Microfinance.
This year’s study was prepared on the occasion of the Swiss Microfinance Platform event held in late November in Geneva that brought together many of the Swiss microfinance actors including government agencies, NGOs , academics, practitioners and founders in order to review and discuss the current microfinance landscape in Switzerland. The 2015 Swiss Microfinance Investments Report is an update of a first report published in 2011 by Symbiotics in collaboration with the Swiss Agency for Development and Cooperation (SDC).
Some key findings include:
- Switzerland remains the market leader in microfinance investments with USD 3.9 billion assets under management as of December 2014 against 2.3 billion in 2010. Eight out 15 largest global products are Swiss-managed or advised investment vehicles.
- Since 2010, Swiss assets under management registered a 15% annual compounded growth compared to a 5% for the global market.
- Private institutional investors remain the top investors with 57% of volumes followed by retail investors, public funders and high net worth individuals (HNWI).
Read full Report here
About the University of Zurich – Center for Microfinance (CMF):
The Center for Microfinance (CMF) is an independent, third-party funded center at the Department of Banking and Finance at the University of Zurich. The CMF was founded in 2009 with the aim to improve the knowledge on the mechanisms of microfinance and to promote a sustainable quality of microfinance investments.
About Symbiotics:
Symbiotics, incorporated in 2004 in Geneva, is an investment company specialized in emerging, sustainable and inclusive finance which offers market research, investment advisory and asset management services. It is an asset manager of collective investment schemes regulated by FINMA, the Swiss Financial Market Supervisory Authority and has an advisory license from the FCA, the Financial Conduct Authority, through its subsidiary in the UK. The company is headquartered in Geneva, with offices in Cape Town, London, Zurich, Mexico City and Singapore with a staff of over eighty professionals.
_
For more information:
Claire Dorey
Communication Manager
claire.dorey@symbioticsgroup.com
Tel: 00 41.22.338.1570
www.symbioticsgroup.com
Dr. Annette Krauss
University of Zurich
Phone: +41 44 634 51 68
www.cmf.uzh.ch
